Wyss Institute for Biologically Inspired Engineering at Harvard University, CLSB Bldg. 5th floor, 3 Blackfan Circle, Boston, MA 02115, USA.
Integr Biol (Camb). 2013 Sep;5(9):1119-29. doi: 10.1039/c3ib40049b.
Kidney toxicity is one of the most frequent adverse events reported during drug development. The lack of accurate predictive cell culture models and the unreliability of animal studies have created a need for better approaches to recapitulate kidney function in vitro. Here, we describe a microfluidic device lined by living human kidney epithelial cells exposed to fluidic flow that mimics key functions of the human kidney proximal tubule. Primary kidney epithelial cells isolated from human proximal tubule are cultured on the upper surface of an extracellular matrix-coated, porous, polyester membrane that splits the main channel of the device into two adjacent channels, thereby creating an apical 'luminal' channel and a basal 'interstitial' space. Exposure of the epithelial monolayer to an apical fluid shear stress (0.2 dyne cm(-2)) that mimics that found in living kidney tubules results in enhanced epithelial cell polarization and primary cilia formation compared to traditional Transwell culture systems. The cells also exhibited significantly greater albumin transport, glucose reabsorption, and brush border alkaline phosphatase activity. Importantly, cisplatin toxicity and Pgp efflux transporter activity measured on-chip more closely mimic the in vivo responses than results obtained with cells maintained under conventional culture conditions. While past studies have analyzed kidney tubular cells cultured under flow conditions in vitro, this is the first report of a toxicity study using primary human kidney proximal tubular epithelial cells in a microfluidic 'organ-on-a-chip' microdevice. The in vivo-like pathophysiology observed in this system suggests that it might serve as a useful tool for evaluating human-relevant renal toxicity in preclinical safety studies.
肾毒性是药物开发过程中最常报告的不良事件之一。缺乏准确的预测细胞培养模型和动物研究的不可靠性,使得人们需要更好的方法来在体外重现肾脏功能。在这里,我们描述了一种由活体人肾上皮细胞排列的微流控装置,该装置暴露于模拟人近端肾小管关键功能的流体流动中。从人近端肾小管分离的原代肾上皮细胞培养在细胞外基质涂覆的多孔聚酯膜的上表面,该膜将装置的主通道分成两个相邻的通道,从而在顶端形成“腔”通道和基底“间质”空间。与传统的 Transwell 培养系统相比,上皮细胞单层暴露于模拟活体肾小管中发现的顶流体切应力(0.2 达因/平方厘米)会导致上皮细胞极化和初级纤毛形成增强。与传统培养条件下维持的细胞相比,这些细胞还表现出显著增强的白蛋白转运、葡萄糖重吸收和刷状缘碱性磷酸酶活性。重要的是,在芯片上测量的顺铂毒性和 Pgp 外排转运蛋白活性比在传统培养条件下维持的细胞的测量结果更接近体内反应。虽然过去的研究已经分析了在体外流动条件下培养的肾小管细胞,但这是首次在微流控“器官芯片”微装置中使用原代人近端肾小管上皮细胞进行毒性研究的报道。该系统中观察到的与体内相似的病理生理学表明,它可能成为在临床前安全性研究中评估与人类相关的肾脏毒性的有用工具。